I am glad to see MST have put out a report that matches our clinical development plan.
Everyone should do their own research in regards value, but the assumptions in these reports can be very helpful when building your own valuation models.
On a personal note, I don’t think I have ever read an analyst report with more conservative assumptions than this one.
General Comments / Chat, page-11586
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.010(0.56%) |
Mkt cap ! $304.2M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.80 | $1.78 | $106.4K | 59.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.83 | 10000 | 2 |
View Market Depth
| Last trade - 15.57pm 30/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |